Interní Med. 2001; 3(6): 270-273

Invazivní versus konzervativní postup u syndromu nestabilní anginy pectoris

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Invazivní versus konzervativní postup u syndromu nestabilní anginy pectoris. Interní Med. 2001;3(6):270-273.

Z materiálů prezentovaných během přednáškového cyklu Controversies in Cardiology při Cardiovascular Institute, The Mount Sinai Medical Center, NYU.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anderson HV, et al for the TIMI IIIB investigators. One year results oh the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. J Am Coll Cardiol 1995, 26: 1643-1650. Go to original source... Go to PubMed...
    2. Boden WE et al for the Veterans Affairs Non Q Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute non Q wave MI randomly assigned to an invasive as compared with a conservative management strategy. A Engl J Med 1998, 338: 1785-1792. Go to original source... Go to PubMed...
    3. Piegas LS et al. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. Am J Cardiol 1999, 84 (suppl) 7M-12M. Go to original source... Go to PubMed...
    4. Theroux P et al.Aspirin, heparin or both to treat unstable angina. A Engl J Med. 1988, 319: 1105-1111. Go to original source... Go to PubMed...
    5. Antman EM, et al. Enoxiparin prevents death and cardiac ischemic events in unstable angina/non Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) IIB Trial. Circulation 1999, 100: 1593-1601. Go to original source... Go to PubMed...
    6. FRISC study group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996, 347: 561-68. Go to original source...
    7. Klein W, Buchwald A et al. Comparision of low-molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary disease. Fragmin in unstable coronary artery disease study (FRIC). Circulation 1997, 96: 61-68. Go to original source... Go to PubMed...
    8. FRAXIS Study Group. Comparison of two treatment durations (6 days and 14 days) of a LMWH with 6 day treatment of unfractionated heparin in the initial management of unstable angina or non Q wavw myocardial infarction: FRAXIS (Fraxiparine in Ischemic Syndrome). Eur Heart J 1999, 20: 1553-5562. Go to original source... Go to PubMed...
    9. Goodman S et al. Randomized trial of low molecular weight heparin (enoxiparine) versus unfractionated heparin for unstable coronary artery disease: One-year result of the Essence study. J AM Coll Card 2000, 36: 693-698. Go to original source... Go to PubMed...
    10. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO)IIB investigators. A Engl J Med 1996, 335: 775-782.
    11. Effects of recombinant hirudin (lepirudin) with heparin on death, MI, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: a randomized trial. Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 1999, 353: 429-38.
    12. The Clopidogrel in Unstable angina to prevent recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J.2000 Dec 15, 21 (24): 2033-2041.
    13. Gent M, Beaumont D et al. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk for Ischemic Events (CAPRIE). Lancet 1996, 348: 1329-1339. Go to original source... Go to PubMed...
    14. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory UA: the CAPTURE Study. Lancet 1997, 349, 1429-1435. Go to original source...
    15. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients limited by Unstable Signs and symptoms (PRISM-PLUS) Study Investigators. Inhibition of platelet GP IIb/IIIa receptor with tirofiban in unstable angina and non Q wave MI. N Engl J Med 1998, 339: 436-443. Go to original source... Go to PubMed...
    16. The PURSUIT Investigators. Inhibition of platelet GP IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med.1998, 339: 436-443. Go to original source... Go to PubMed...
    17. Arntz HR, et al. Beneficial Effects of Pravastatin (+Colestyramin/Niacin) Initiated Immediately After a Coronary Event (The Randomized Lipid-Coronary Artery Disease L-CAD Study). Am J Card 2000, 86: 1293-1298. Go to original source... Go to PubMed...
    18. Schwartz GG, et al. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non Q MI. Am J Cardiol 1998, 81: 578-581. Go to original source... Go to PubMed...
    19. McCullough PA et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the MATE trial. J Am Coll Cardiol 1998, 32: 596-605. Go to original source... Go to PubMed...
    20. Cannon CP, et al. Invasive versus conservative strategies in unstable angina and non Q MI following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Am J Cardiol. 1998 Sep 15: 82 (6): 731-6. Go to original source... Go to PubMed...
    21. Bhatt DL, Topol EJ. Current Role of Platelet GP IIb/IIIa Inhibitors in Acute Coronary Syndromes. JAMA 2000, 284: 1549-1558. Go to original source... Go to PubMed...
    22. Wallentin L et al. Outcome at 1 year after an invasive compared with noninvasive strategy in unstable coronary art.disease: the FRISC II invasive randomized trial. Lancet 2000, 356: 9-16. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.